Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03565146
Other study ID # Focus-PiQo4 Pigmentation-17-01
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 29, 2018
Est. completion date June 5, 2019

Study information

Verified date June 2018
Source Focus Medical, LLC
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

A total of at least 25 healthy subjects at a single site, aged 21-70 years old with congenital or acquired challenging/resistant, age/sun-related flat and benign facial pigmentation with or without hand pigmentation who wish to improve their skin appearance.


Recruitment information / eligibility

Status Completed
Enrollment 25
Est. completion date June 5, 2019
Est. primary completion date June 5, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 21 Years to 70 Years
Eligibility Inclusion Criteria:

1. Healthy Female or Male

2. Age= 21-70 (Adults)

3. Fitzpatrick skin phototype = I-V

4. Congenital or acquired benign pigmentation on face with optional pigmentation on hand.

5. Presence of at least 4 lesions of similar pigmentation intensity in the treatment area, in diameters larger than 2 mm

6. Able to read, understand and provide written Informed Consent

7. Able and willing to comply with the treatment/follow-up schedule and requirements

8. Women of child-bearing potential are required to use a reliable method of birth control (such as an intrauterine device, birth control pills, condom with spermicidal, NuvaRing, partner with vasectomy, Implanon or other FDA-approved devices, or abstinence) during the course of the study

9. Willing to have digital photographs taken of the treatment area

10. Willing to refrain from using any prescription or over the counter topical creams used for the treatment of pigmentation (e.g., hydroquinone, retinoids, and/or corticosteroids) in the treatment area during the study period.

11. Willing to protect from sun exposure and use an approved sunscreen of SPF 30 or higher in the treatment area daily during the entire duration of the study, including the follow-up period.

12. Agree not to undergo any other procedure(s) for the treatment of pigmentation or solar lentigines during the study.

Exclusion Criteria:

1. History of post inflammatory pigmentary disorders, particularly a tendency for hyper- or hypo-pigmentation

2. Melasma

3. Excessive underlying vascular conditions (e.g. dense network of capillaries)

4. Pregnant, intending to become pregnant during the course of study, less than 3 months postpartum or less than 3 months after completion of breastfeeding

5. Prior skin laser, light, or other energy device treatment in treated area within 6 months of initial treatment or during the course of the study

6. Prior ablative resurfacing procedure or face-lift in treated area with laser or other devices within 12 months of initial treatment or during the course of the study

7. Prior treatment with medium-depth or deeper chemical peels or dermabrasion in treated area within 3 months of initial treatment or during the course of the study

8. Prior use of any prescription or over the counter topical creams used for the treatment of pigmentation (e.g., hydroquinone, retinoids, and/or corticosteroids) in the treatment area within 3 months of initial treatment or during the course of the study

9. Any other surgery in treated area within 9 months of initial treatment or during the course of the study

10. Hypersensitive to light exposure or the use of photosensitive medication for which light exposure is contraindicated

11. Multiple dysplastic nevi in area to be treated

12. Significant concurrent illness (e.g. uncontrolled diabetes) or any disease state that in the opinion of the Investigator would interfere with the treatment or healing process

13. Any dermal/epidermal damage or disorder, mainly vascular or textural lesions, in the treatment area.

14. Any underlying tattoo in the treatment area.

15. Unable or unlikely to refrain from tanning, including the use of tanning booths, during the course of the study

16. Participation in a study of another investigational device or drug involving the same anatomical site within 3 months prior to enrollment or during this evaluation, or if not involving the same anatomical site, as per the Investigator's discretion

17. History of keloid or any other type of hypertrophic scar formation or poor wound healing

18. Signs and symptoms of hormonal disorders such as Melasma, as per the Investigator's discretion.

19. Concurrent inflammatory skin conditions, open laceration, or abrasion of any sort on area to be treated during the course of treatment

20. Active Herpes Simplex (perioral or facial) at the time of treatment or having experienced more than three episodes of Herpes Simplex eruption within a year of study enrollment

21. Having a bleeding disorder or taking anticoagulation medications, including daily use of aspirin, in a manner which does not allow for a minimum 10 day washout period prior to treatment (as per the discretion of the subject's primary care physician)

22. History of immunosuppression/immune deficiency disorders (including HIV infection or AIDS) or the use of immunosuppressive medications

23. Having any form of active cancer at the time of enrollment and during the course of the study or history of skin cancer on the face/hands

24. Pigmented lesions in the areas to be treated that are suspicious for pre-malignancy or malignancy and/or are not deemed suitable for phototherapy, as per the Investigator's discretion

25. Unable to understand or provide written Informed Consent (e.g. mental incompetence or evidence of active substance abuse)

26. Any condition that, in the Investigator's opinion, would make it unsafe (for the subject or for the study personnel) to treat the subject as part of this research study

27. If undergoing punch biopsy, allergic to lidocaine or epinephrine

Study Design


Related Conditions & MeSH terms


Intervention

Device:
PiQo4 Laser System
PiQo4 Laser System for treatment of pigmented lesions

Locations

Country Name City State
United States Westlake Dermatology Austin Texas

Sponsors (1)

Lead Sponsor Collaborator
Focus Medical, LLC

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Pigmentation Improvement Scale Facial Pigmentation Improvement evaluated by the investigator at the 1 month follow up visit compared to baseline using a 5-point improvement scale where a score of between 0 and 4 will be assigned (0-No improvement; 1- Trace to mild improvement of some lesions; 2- Moderate response: some lesions lighter; 3- Good response: most lesions much lighter; 4 - excellent response: most or all lesions are much lighter or gone) 1 month follow up
Secondary Pigmentation Improvement Scale Facial Pigmentation Improvement evaluated by the investigator at the 3 month follow up visit compared to baseline using a 5-point improvement scale where a score of between 0 and 4 will be assigned (0-No improvement; 1- Trace to mild improvement of some lesions; 2- Moderate response: some lesions lighter; 3- Good response: most lesions much lighter; 4 - excellent response: most or all lesions are much lighter or gone) 3 month follow up
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05913102 - A Prospective, Split-face, Randomized Study of the Poly-D, L Lactic Acid (PDLLA) for Photoaged Skin N/A
Recruiting NCT04539561 - Evaluation of the Efficacy and Safety of PiQo4 for the Treatment of Hand Pigmentation Using 1064nm PSL and 532nm PSL N/A
Completed NCT05750914 - Evaluation of Broadband Light Treatment for Pigmented Skin Lesions N/A
Recruiting NCT06074276 - The Effects of Almond on Facial Skin Collagen and Wrinkles N/A
Completed NCT05662592 - Evaluation of Broadband Light Treatment Protocol for Pigmented Skin Lesions - A Comparative Study N/A
Recruiting NCT05847530 - Pilot Evaluation of the Cynosure Potenza™ System for Treatment of Cosmetic Dermatologic Skin Conditions N/A
Enrolling by invitation NCT01847066 - Epidermal Delivery of Ani-Aging Ingredients N/A
Completed NCT03065582 - The Effect of Topical Sunscreen Plus Antioxidant Against the Visible Light Biological Effects N/A
Completed NCT04493021 - Evaluation of the Dermal Cooling System for the Enhanced Treatment of Benign Pigmented Lesions and Common Skin Conditions N/A
Terminated NCT02506101 - Randomized, Split-body, Single-blinded Clinical Trial of NB-UVB Treatment for Vitiligo N/A
Not yet recruiting NCT05160103 - 16-Week Randomized Split-Face Efficacy Study of Cosmetic Formulations in Photoaged Pigmented Skin Subjects N/A
Completed NCT06075641 - Post Gingival Depigmentation Assessment: Comparison of Surgical Stripping vs (Er,Cr:YSGG) Laser N/A
Completed NCT01885091 - Efficacy and Safety Study of Kinerase® for Treatment of Cutaneous Facial Photodamage Phase 4
Completed NCT05710068 - Effects of RF Microneedle on Photoaging Skin N/A
Completed NCT05304624 - Comparison of Er,Cr:YSGG Laser and Diode Laser in the Treatment of Gingival Melanin Pigmentation N/A
Recruiting NCT04865094 - Photoprotection Efficacy With Sunscreen Formulas Containing the Cyclic Merocyanine Long-UVA Absorber MCE Under Long-UVA Exposure N/A
Recruiting NCT04866797 - Photoprotection Efficacy With Sunscreen Formulas Containing the Cyclic Merocyanine Long-UVA Absorber MCE Under UV Day Light Exposure N/A
Completed NCT04881058 - Post Market Clinical Follow Up Study to Collect Additional Data and Imaging N/A
Completed NCT03970317 - Safety and Efficacy of Broad Band Light In Motion Treatment N/A